Literature DB >> 16103997

Structure and morphology of the Alzheimer's amyloid fibril.

Thusnelda Stromer1, Louise C Serpell.   

Abstract

Amyloid fibrils are deposited in a number of diseases, including Alzheimer's disease, Type 2 diabetes, and the transmissible spongiform encephalopathies (TSE). These insoluble deposits are formed from normally soluble proteins that assemble to form fibrous aggregates that accumulate in the tissues. Electron microscopy has been used as a tool to examine the structure and morphology of these aggregates from ex vivo materials, but predominantly from synthetic amyloid fibrils assembled from proteins or peptides in vitro. Electron microscopy has shown that the fibrils are straight, unbranching, and are of a similar diameter (60-100 A) irrespective of the precursor protein. Image processing has enhanced electron micrographs to show that amyloid fibrils appear to be composed of protofilaments wound around one another. In combination with other techniques, including X-ray fiber diffraction and solid state NMR, electron microscopy has revealed that the internal structure of the amyloid fibril is a ladder of beta-sheet structure arranged in a cross-beta conformation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103997     DOI: 10.1002/jemt.20190

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  23 in total

Review 1.  Nanoimaging for protein misfolding and related diseases.

Authors:  Yuri L Lyubchenko; Simon Sherman; Luda S Shlyakhtenko; Vladimir N Uversky
Journal:  J Cell Biochem       Date:  2006-09-01       Impact factor: 4.429

2.  Molecular origin of the self-assembly of lanreotide into nanotubes: a mutational approach.

Authors:  Céline Valéry; Emilie Pouget; Anjali Pandit; Jean-Marc Verbavatz; Luc Bordes; Isabelle Boisdé; Roland Cherif-Cheikh; Franck Artzner; Maité Paternostre
Journal:  Biophys J       Date:  2007-11-09       Impact factor: 4.033

3.  Nonnative protein polymers: structure, morphology, and relation to nucleation and growth.

Authors:  William F Weiss; Travis K Hodgdon; Eric W Kaler; Abraham M Lenhoff; Christopher J Roberts
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

4.  Characterization of an antibody scFv that recognizes fibrillar insulin and beta-amyloid using atomic force microscopy.

Authors:  Warren D Marcus; Hongda Wang; Stuart M Lindsay; Michael R Sierks
Journal:  Nanomedicine       Date:  2008-01-16       Impact factor: 5.307

Review 5.  Structural basis of infectious and non-infectious amyloids.

Authors:  Ulrich Baxa
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

6.  Differences in β-strand populations of monomeric Aβ40 and Aβ42.

Authors:  K Aurelia Ball; Aaron H Phillips; David E Wemmer; Teresa Head-Gordon
Journal:  Biophys J       Date:  2013-06-18       Impact factor: 4.033

Review 7.  Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases.

Authors:  Anna Villar-Piqué; Matthias Schmitz; Niccolò Candelise; Salvador Ventura; Franc Llorens; Inga Zerr
Journal:  Mol Neurobiol       Date:  2018-02-10       Impact factor: 5.590

Review 8.  Fibrillogenesis of huntingtin and other glutamine containing proteins.

Authors:  Yuri L Lyubchenko; Alexey V Krasnoslobodtsev; Sorin Luca
Journal:  Subcell Biochem       Date:  2012

9.  Time-dependent insulin oligomer reaction pathway prior to fibril formation: cooling and seeding.

Authors:  Mirco Sorci; Robert A Grassucci; Ingrid Hahn; Joachim Frank; Georges Belfort
Journal:  Proteins       Date:  2009-10

10.  Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE.

Authors:  Nicola Origlia; Simona Capsoni; Antonino Cattaneo; Fang Fang; Ottavio Arancio; Shi Du Yan; Luciano Domenici
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.